| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/06/2013 | WO2013025916A3 Dermal rejuvenation compositions and methods |
| 06/06/2013 | WO2013019917A3 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
| 06/06/2013 | WO2013019733A3 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 06/06/2013 | WO2012153339A3 Stevia based sweetening composition |
| 06/06/2013 | WO2012137054A9 Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration |
| 06/06/2013 | US20130144264 Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions |
| 06/06/2013 | US20130144239 Lotions derived from renewable resources and absorbent articles comprising same |
| 06/06/2013 | US20130144045 Novel self-reactive arms and prodrugs comprising same |
| 06/06/2013 | US20130144043 Polysialic acid derivatives |
| 06/06/2013 | US20130144014 Multi-arm block copolymers as drug delivery vehicles |
| 06/06/2013 | US20130143979 Precursor composition for crosslinkable pressure-sensitive adhesive for skin |
| 06/06/2013 | US20130143965 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/06/2013 | US20130143963 Sulforaphane stabilization |
| 06/06/2013 | US20130143958 Dosage unit comprising a prostaglandin analog for treating constipation |
| 06/06/2013 | US20130143949 G-CSF Transferrin Fusion Proteins |
| 06/06/2013 | US20130143936 2-iminobiotin formulations and uses thereof |
| 06/06/2013 | US20130143909 Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods |
| 06/06/2013 | US20130143801 Methods and compositions for delivering peptides |
| 06/06/2013 | US20130143798 Novel glucagon analogues |
| 06/06/2013 | US20130143316 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 06/06/2013 | US20130143268 Method of producing the polypeptide for treating virus-induced cancer |
| 06/06/2013 | US20130142892 Herbal extract composition |
| 06/06/2013 | US20130142877 Pharmaceutical dosage form comprising one or more antiretroviral active ingredients |
| 06/06/2013 | US20130142874 Pharmaceutical compositions based on diclofenac |
| 06/06/2013 | US20130142866 Compositions and methods for improved organ transplant preservation and acceptance |
| 06/06/2013 | US20130142849 Controlled release formulations of dronedarone |
| 06/06/2013 | US20130142837 Cellulosic gel composition with improved viscosity stability |
| 06/06/2013 | US20130142834 Local delivery of drugs from self assembled coatings |
| 06/06/2013 | US20130142821 Hapten-Carrier Conjugates and Uses Thereof |
| 06/06/2013 | US20130142797 Method of treating virus-induced cancer |
| 06/06/2013 | US20130142791 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 06/06/2013 | US20130142781 Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants |
| 06/06/2013 | US20130142752 Controlled release of biologically active compounds |
| 06/06/2013 | US20130142733 Multifunctional degradable nanoparticles with control over size and functionalities |
| 06/06/2013 | US20130142731 Threads of cross-linked hyaluronic acid and methods of use thereof |
| 06/06/2013 | US20130142729 Anti-CD74 Immunoconjugates and Methods of Use |
| 06/06/2013 | CA2857592A1 Composition based on ubidecarenone |
| 06/06/2013 | CA2857567A1 Targeted lysosomal enzyme compounds |
| 06/06/2013 | CA2857548A1 Targeted enzyme compounds and uses thereof |
| 06/06/2013 | CA2857539A1 Bacteriophage gene 3 protein compositions and use as amyloid binding agents |
| 06/06/2013 | CA2857501A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
| 06/06/2013 | CA2857287A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | CA2857156A1 Ropinirole-containing adhesive patch |
| 06/06/2013 | CA2855566A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | CA2854194A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 06/06/2013 | CA2854054A1 Amphipathic lipid-based sustained release compositions |
| 06/05/2013 | EP2599504A2 Use of conjugates of fsh receptor ligands and antitumour agents for therapy of cancer |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599502A2 Method for preparation of site-specific protein conjugates |
| 06/05/2013 | EP2599501A1 Adhesive patch for medical use |
| 06/05/2013 | EP2599500A1 Adhesive patch for medical use |
| 06/05/2013 | EP2599497A2 Porphyrazine-chemotherapeutic agents conjugates |
| 06/05/2013 | EP2599486A1 Dronedarone solid dispersion and preparation method thereof |
| 06/05/2013 | EP2599485A1 Fat-containing composition and oral formulation containing same |
| 06/05/2013 | EP2599483A1 4-Phenylbutyric acid formulation |
| 06/05/2013 | EP2599473A1 Astaxanthin-containing aqueous composition, cosmetic preparation, and method for suppressing degradation of astaxanthin |
| 06/05/2013 | EP2598172A1 Nucleophilic catalysts for oxime linkage |
| 06/05/2013 | EP2598171A2 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 06/05/2013 | EP2598170A2 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 06/05/2013 | EP2598167A1 Stabilized aqueous antibody compositions |
| 06/05/2013 | EP2598160A2 Stabilization of fsh |
| 06/05/2013 | EP2598156A1 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
| 06/05/2013 | EP2598148A2 Pharmaceutical compositions containing pemetrexed having extended storage stability |
| 06/05/2013 | EP2598132A1 Composition for the treatment and prevention of herpes simplex labialis |
| 06/05/2013 | EP2598120A2 Compositions and methods for inducing immune tolerance |
| 06/05/2013 | EP2598116A2 Ph-dependent gradual release pharmaceutical composition |
| 06/05/2013 | CN202961198U Novel preparation of d-limonene hard capsule |
| 06/05/2013 | CN1798545B Method for improving stability and shelf-life of liposome complexes |
| 06/05/2013 | CN103140512A Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 06/05/2013 | CN103140499A A novel conjugate of granulocyte colony-stimulating factor (g-csf) with polyethylene glycol |
| 06/05/2013 | CN103140243A Probiotic liquid food products |
| 06/05/2013 | CN103140226A Preparation for treatment of spinal cord injury |
| 06/05/2013 | CN103140225A Methods of treatment of pancreatic cancer |
| 06/05/2013 | CN103140216A A water-in-oil type emulsion for treating a disease of the eye |
| 06/05/2013 | CN103140215A Pharmaceutical composition with enhanced solubility characteristics |
| 06/05/2013 | CN103131687A Polyethylene glycol covalent modification lysostaphin and prepared method and application thereof |
| 06/05/2013 | CN103131647A Baby bifidobacterium and preparation thereof |
| 06/05/2013 | CN103131014A Degradation method for preparing amphipathicity copolymer of polycaprolactone and polyethylene glycol |
| 06/05/2013 | CN103131005A Amino acid block copolymer and preparation method and compound thereof |
| 06/05/2013 | CN103130966A A silicone acrylate hybrid composition and method of making same |
| 06/05/2013 | CN103130912A One-step method of preparing covalence crosslinked and hydrophobic modified sodium alga acid hydrogel |
| 06/05/2013 | CN103130898A TAT-LBD-PEP fusion protein and application of TAT-LBD-PEP fusion protein in treatment of central nervous system lesion |
| 06/05/2013 | CN103130829A Production method of injection-use hydrogenated soybean lecithin |
| 06/05/2013 | CN103130662A V-shaped cation aqueous cosolvent, polymer of the V-shaped cation aqueous cosolvent, synthesis methods of the V-shaped cation aqueous cosolvent and the polymer, and use of the polymer |
| 06/05/2013 | CN103127543A Silicone dressing, and preparation method and use thereof |
| 06/05/2013 | CN103127527A Treatment of diabetes mellitus by taking insulin PEGylation derivative as active component |
| 06/05/2013 | CN103127526A Tree-like polymer targeting nanometer drug delivery carrier and its preparation method |
| 06/05/2013 | CN103127525A Tree-like polymer nanometer drug delivery carrier targeting doxorubicin and its preparation method |
| 06/05/2013 | CN103127524A Preparation method of polyamide-amine dendrimer-loaded alpha-Tos |
| 06/05/2013 | CN103127523A Psma antibody-drug conjugates |
| 06/05/2013 | CN103127522A Conjugate of fatty acid-curcumin derivative and application thereof |
| 06/05/2013 | CN103127521A Drug carrier with chelating composite micell and use thereof |
| 06/05/2013 | CN103127520A Combination of polyethylene glycol and tamsulosin and pharmaceutical compound comprising same |
| 06/05/2013 | CN103127519A Sea-tangle glue capsule membrane material and manufacturing process thereof |
| 06/05/2013 | CN103127518A Hydrogel matrix composition and preparation method thereof |
| 06/05/2013 | CN103127517A Method for preparing medicinal premixed ingredients |
| 06/05/2013 | CN103127516A Drug sustained release preparation and preparation method thereof |
| 06/05/2013 | CN103127515A Traditional Chinese medicine cataplasm matrix composition and preparation method thereof |
| 06/05/2013 | CN103127514A Medicine sustained-release suppository capable of internal injection |